0001415889-22-004334.txt : 20220428
0001415889-22-004334.hdr.sgml : 20220428
20220428211850
ACCESSION NUMBER: 0001415889-22-004334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220426
FILED AS OF DATE: 20220428
DATE AS OF CHANGE: 20220428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Connor Donal
CENTRAL INDEX KEY: 0001625377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 22869629
MAIL ADDRESS:
STREET 1: C/O PERRIGO COMPANY PLC
STREET 2: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
form4-04282022_060449.xml
X0306
4
2022-04-26
0001583107
Theravance Biopharma, Inc.
TBPH
0001625377
O'Connor Donal
C/O THERAVANCE BIOPHARMA US, INC
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Ordinary Shares
2022-04-26
4
A
0
9852
0
A
53886
D
Share Option (Right to Buy)
10.15
2022-04-26
4
A
0
28000
0
A
2032-04-25
Ordinary Shares
28000
28000
D
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
/s/ Brett A. Grimaud, Attorney-in-Fact
2022-04-28